FDA “Critical Path” Workshop
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is planning to hold a public workshop designed to improve the development of biological products as part of its "Critical Path" initiative.
You may also be interested in...
FDA Plans “Critical Path” Workshop On Prevention Therapies
Two-day meeting will focus on both broad and disease-specific topics related to prevention development hurdles.
FDA Plans “Critical Path” Workshop On Prevention Therapies
Two-day meeting will focus on both broad and disease-specific topics related to prevention development hurdles.
Agency Will Fund Research On Development Roadblocks; Orphan Drug Grants Are Model
FDA is going to fund research projects aimed at eliminating barriers to product development as part of its "critical path" initiative